サンプル依頼リスト カート
  • English
  • Korean
表紙：腫瘍溶解性ウイルス免疫療法の世界市場：製品タイプ別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024～2032年）
市場調査レポート
商品コード
1408906

腫瘍溶解性ウイルス免疫療法の世界市場：製品タイプ別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024～2032年）

Oncolytic Virus Immunotherapy Market, By Product Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 298 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
腫瘍溶解性ウイルス免疫療法の世界市場：製品タイプ別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024～2032年）
出版日: 2024年01月13日
発行: AnalystView Market Insights
ページ情報: 英文 298 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートのハイライト

世界の腫瘍溶解性ウイルス免疫療法の市場規模は、2023年に1億1,000万米ドルとなり、2024～2032年にかけてCAGR 24.5%で拡大すると予測されています。

腫瘍溶解性ウイルス免疫療法市場 - 市場力学

市場需要を促進する共同研究の増加

共同研究の増加は、予測期間中の市場成長を促進すると予想されます。例えば、2022年1月、Siga Technologies社とBioarchitech社は、がん治療としての免疫療法を研究するための前臨床パートナーシップを締結しました。TPOXX（tecovirimat）とBioarchitechの特許である「vaccinia-based immunotherapy platform」は、腫瘍溶解性ウイルスのゲノムに見られるテーラーメイドの抗体やその他のタンパク質を利用するもので、この研究提携の対象です。さらに、2024年1月には、IT・ネットワーク・AI技術のリーダーであるNECと、がん治療のためのウイルスベースの免疫療法を設計・開発するバイオテクノロジー企業であるトランスジーン社との間で、さらなる開発協力契約が締結され、カスタマイズされた新抗原がんワクチンTG4050の臨床評価が継続される予定です。

腫瘍溶解性ウイルス免疫療法市場 - 主要洞察

  • 世界市場は予測期間（2024～2032年）に約24.5%のCAGRで毎年成長すると予測されています。
  • 用途セグメンテーションに基づくと、前立腺がんは予測期間中にかなりの速度で成長すると予想されます。
  • エンドユーザーセグメンテーションに基づくと、病院セグメントが予測期間中に市場を独占すると予想されます。
  • 地域別では、北米が予測期間中に顕著な市場シェアを占めると予想されます。

腫瘍溶解性ウイルス免疫療法市場 - セグメンテーション分析：

  • 腫瘍溶解性ウイルス免疫療法の世界市場は、製品タイプ、用途、エンドユーザー、地域に基づいて区分されます。
  • 製品タイプに基づけば、市場はワクシニアウイルスベースの腫瘍溶解ウイルス、水疱性口内炎ウイルスベースの腫瘍溶解ウイルス、HSVベースの腫瘍溶解ウイルス、アデノウイルスベースの腫瘍溶解ウイルス、ニューカッスル病ウイルスベースの腫瘍溶解ウイルスに二分されます。
  • 用途に基づき、世界の産業は前立腺がん、膀胱がん、黒色腫、卵巣がん、乳がん、肺がん、骨髄腫、その他に区分されます。前立腺がんは、予測される期間中に大きな成長率で成長すると予想されています。このセグメントの成長は、前立腺がんの有病率の増加に起因しています。例えば、二次分析によると、皮膚がんを除いて、前立腺がんは男性の間で最も頻度の高いがんです。米国では2023年に28万8,300人の男性が前立腺がんの診断を受けると推定されています。2020年には、世界中で141万4,259人が前立腺がんの診断を受けると予測されています。前立腺がんは、世界で4番目に罹患率の高いがんです。
  • エンドユーザーに基づき、市場は専門クリニック、病院、がん研究機関に分けられます。予測期間中、病院セグメントが市場を独占すると予想されます。有資格の医療スタッフが治療中も治療後も患者を見守ることができる病院では、通常、抗凝固ウイルス免疫療法が行われます。また、病院は腫瘍溶解性ウイルス免疫療法の臨床試験に頻繁に参加しています。多くのがん種において、これらの研究は特定の治療法の安全性と有効性を評価するものです。

腫瘍溶解性ウイルス免疫療法市場 - 地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。北米は、他の国に比べて患者数が増加しているため、予測期間中に顕著な市場シェアを占めると予想されます。米国ではがん罹患率が上昇した結果、市場が拡大しています。米国がん協会の2021年報告書によると、米国では2021年に60万8,570人ががんで死亡する一方、190万人の新規がん患者が確認されると予測されています。市場の成長に寄与するその他の理由としては、さまざまながん治療に関する知識の増加、高度な免疫腫瘍学治療薬がこの地域で利用可能になったこと、米国などの国々におけるヘルスケア支出の拡大などが挙げられます。メディケア・メディケイド・サービスセンター（CMS）が発表したデータによると、米国の医療費は2020年に9.7％増加し、4兆1,000億米ドル、1人当たり1万2,530米ドルに達します。医療費は国内総生産（GDP）の19.7％を占める。このため、同地域の市場拡大の原動力となっています。

腫瘍溶解性ウイルス免疫療法市場-競合情勢：

同市場に参入している主要企業は以下の通り：Amgen, Inc.、Sorrento Therapeutics Inc.、Merck &Co., Inc.、Oncolytics Biotech, Inc.、Viralytics Ltd.、Shanghai Sunway Biotech Co., Ltd.、SillaJen, Inc.、RIGVIR Ltd.、ORYX GmbH & Co.KG、Cold Genesys, Inc.、Transgene Biotek Ltd.などです。これらの企業は、市場競争力を維持するために、製品発売、買収、提携、契約など様々な戦略を採用しています。

目次

第1章 腫瘍溶解性ウイルス免疫療法の市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 腫瘍溶解性ウイルス免疫療法の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 腫瘍溶解性ウイルス免疫療法の産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 腫瘍溶解性ウイルス免疫療法市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 腫瘍溶解性ウイルス免疫療法の市場情勢

  • 腫瘍溶解性ウイルス免疫療法市場シェア分析、2023年
  • 内訳データ：主要メーカー別
    • 既存企業の分析
    • 新興企業の分析

第7章 腫瘍溶解性ウイルス免疫療法市場：製品タイプ別

  • 概要
    • セグメントシェア分析：製品タイプ別
    • ワクシニアウイルスベースの腫瘍溶解性ウイルス
    • 水疱性口内炎ウイルスベースの腫瘍溶解性ウイルス
    • HSVベースの腫瘍溶解性ウイルス
    • アデノウイルスベースの腫瘍溶解性ウイルス
    • ニューカッスル病ウイルスベースの腫瘍溶解性ウイルス

第8章 腫瘍溶解性ウイルス免疫療法市場：用途別

  • 概要
    • セグメントシェア分析：用途別
    • 前立腺がん
    • 膀胱がん
    • 黒色腫
    • 卵巣がん
    • 乳がん
    • 肺がん
    • 骨髄腫
    • その他

第9章 腫瘍溶解性ウイルス免疫療法市場：エンドユーザー別

  • 概要
    • セグメントシェア分析：エンドユーザー別
    • 専門クリニック
    • 病院
    • がん調査

第10章 腫瘍溶解性ウイルス免疫療法市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：腫瘍溶解性ウイルス免疫療法産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Amgen, Inc.
    • Sorrento Therapeutics Inc.
    • Merck &Co., Inc.
    • Oncolytics Biotech, Inc.
    • Viralytics Ltd.
    • Shanghai Sunway Biotech Co., Ltd.
    • SillaJen, Inc.
    • RIGVIR Ltd.
    • ORYX GmbH &Co. KG
    • Cold Genesys, Inc.
    • Transgene Biotek Ltd.

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Oncolytic Virus Immunotherapy Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Oncolytic Virus Immunotherapy Market, by Product Type 2019-2032 (USD Million)
  • TABLE Oncolytic Virus Immunotherapy Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Oncolytic Virus Immunotherapy Market, by Application 2019-2032 (USD Million)
  • TABLE Oncolytic Virus Immunotherapy Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Oncolytic Virus Immunotherapy Market, by End-User 2019-2032 (USD Million)
  • TABLE Oncolytic Virus Immunotherapy Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Oncolytic Virus Immunotherapy Market, by Region 2019-2032 (USD Million)
  • TABLE North America Oncolytic Virus Immunotherapy Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Oncolytic Virus Immunotherapy Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Oncolytic Virus Immunotherapy Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Oncolytic Virus Immunotherapy Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Oncolytic Virus Immunotherapy Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Oncolytic Virus Immunotherapy Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Oncolytic Virus Immunotherapy Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Oncolytic Virus Immunotherapy Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Oncolytic Virus Immunotherapy Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Oncolytic Virus Immunotherapy Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Oncolytic Virus Immunotherapy Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Oncolytic Virus Immunotherapy Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Oncolytic Virus Immunotherapy Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Oncolytic Virus Immunotherapy Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Oncolytic Virus Immunotherapy Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Oncolytic Virus Immunotherapy Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Oncolytic Virus Immunotherapy Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Oncolytic Virus Immunotherapy Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Oncolytic Virus Immunotherapy Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Oncolytic Virus Immunotherapy Market, by End-User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Oncolytic Virus Immunotherapy Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End-User segment market share analysis, 2023 & 2032
  • FIGURE End-User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Oncolytic Virus Immunotherapy Market share and leading players, 2023
  • FIGURE Europe Oncolytic Virus Immunotherapy Market share and leading players, 2023
  • FIGURE Asia Pacific Oncolytic Virus Immunotherapy Market share and leading players, 2023
  • FIGURE Latin America Oncolytic Virus Immunotherapy Market share and leading players, 2023
  • FIGURE Middle East and Africa Oncolytic Virus Immunotherapy Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Oncolytic Virus Immunotherapy Market share analysis by country, 2023
  • FIGURE Germany Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Oncolytic Virus Immunotherapy Market share analysis by country, 2023
  • FIGURE India Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Oncolytic Virus Immunotherapy Market share analysis by country, 2023
  • FIGURE Brazil Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Oncolytic Virus Immunotherapy Market share analysis by country, 2023
  • FIGURE Saudi Arabia Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV2075

REPORT HIGHLIGHT

Oncolytic Virus Immunotherapy Market size was valued at USD 110 Million in 2023, expanding at a CAGR of 24.5% from 2024 to 2032.

The oncolytic viral immunotherapy includes the use of viruses to infect and then kill cells with cancer. It is well-recognized that cancer cells have weakened antiviral defenses, leaving them more vulnerable to infections than healthy body cells. Oncolytic viruses are designed to deliver therapeutic payloads to tumor cells while exhibiting a reduced capacity to infect healthy cells.

Oncolytic Virus Immunotherapy Market- Market Dynamics

Increasing collaboration to propel market demand

The increasing collaboration is expected to propel the market growth during the forecast period. For instance, in January 2022, Siga Technologies and Bioarchitech formed a preclinical partnership to study immunotherapy as a cancer treatment. The TPOXX (tecovirimat) and Bioarchitech's patented "vaccinia-based immunotherapy platform," which makes use of tailored antibodies and other proteins found in the oncolytic virus's genome, are the subjects of the research partnership. Moreover, in January 2024, the clinical evaluation of the customized neoantigen cancer vaccine TG4050 will continue due to the signing of a further development collaboration agreement by NEC Corporation, a leader in IT, network, and AI technologies, and Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer.

Oncolytic Virus Immunotherapy Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 24.5% over the forecast period (2024-2032)
  • Based on application segmentation, prostate cancer is expected to grow at a significant rate over the projected timeframe
  • Based on end-user segmentation, the hospitals segment is expected to dominate the market during the forecast period
  • Based on region, North America is expected to hold a prominent market share during the forecast period

Oncolytic Virus Immunotherapy Market- Segmentation Analysis:

  • The Global Oncolytic Virus Immunotherapy Market is segmented based on Product Type, Application, End-User, and Region.
  • Based on the product type, the market is bifurcated into Vaccinia Virus-based Oncolytic Viruses, Vesicular Stomatitis Virus-based Oncolytic Viruses, HSV-based Oncolytic Viruses, Adenovirus-based Oncolytic Viruses and Newcastle Disease Virus-based Oncolytic Viruses.
  • Based on the application, the global industry is segmented into Prostate Cancer, Bladder Cancer, Melanoma, Ovarian Cancer, Breast Cancer, Lung Cancer, Myeloma and Others. Prostate cancer is expected to grow at a significant rate over the projected timeframe. The growth in the segment is attributed to the increasing prevalence of prostate cancer. For instance, according to secondary analysis, except for skin cancer, prostate cancer is the most frequent cancer among males. An estimated 288,300 males in the US will receive a prostate cancer diagnosis in 2023. In 2020, a projected 1,414,259 individuals received a prostate cancer diagnosis worldwide. It ranks as the fourth most prevalent kind of cancer worldwide.
  • Based on the end-user, the market is divided into Specialty Clinics, Hospitals and Cancer Research Institutes. The hospital segment is expected to dominate the market during the forecast period. In a hospital setting, where qualified medical staff can keep an eye on patients both during and after treatment, oncolytic viral immunotherapy is usually given. Hospitals are also frequently participating in oncolytic virus immunotherapy clinical studies. In many cancer types, these studies evaluate the safety and effectiveness of certain treatments.

Oncolytic Virus Immunotherapy Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold a prominent market share during the forecast period because the number of patients is growing in comparison to other nations. The market is expanding as a result of the United States' increased cancer incidence rates. According to the American Cancer Society's 2021 report, 608,570 people died from cancer in the US in 2021, while an anticipated 1.9 million new cases of cancer were identified. The other reasons that contribute to the growth of the market include increased knowledge about different cancer therapies, the availability of sophisticated immune-oncology medications in the area, and the expanding healthcare spending in countries such as the United States. The Centers for Medicare and Medicaid Services (CMS) released data showing that U.S. healthcare spending increased by 9.7% in 2020 to reach USD 4.1 trillion, or USD 12,530 per person. Health spending made up 19.7 percent of the country's GDP. Thus, driving the market expansion in the region.

Oncolytic Virus Immunotherapy Market- Competitive Landscape:

The key players operating in the market are: Amgen, Inc., Sorrento Therapeutics Inc., Merck & Co., Inc., Oncolytics Biotech, Inc., Viralytics Ltd., Shanghai Sunway Biotech Co., Ltd., SillaJen, Inc., RIGVIR Ltd., ORYX GmbH & Co. KG, Cold Genesys, Inc. and Transgene Biotek Ltd. These players adopted various strategies to remain competitive in the market which include, product launches, acquisitions, collaboration, agreements and others.

Recent Developments:

In July 2022, ABL, a pure play Contract Development and Manufacturing Organization (CDMO) focused on the creation and production of viruses for gene and cancer therapies, vaccine candidates, and other applications, announced its collaboration with KaliVir Immunotherapeutics, a privately held biotech business creating state-of-the-art, next-generation oncolytic viral immunotherapy programs. For the impending clinical study, ABL will produce the oncolytic viruses developed by KaliVir.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Amgen, Inc.
  • Sorrento Therapeutics Inc.
  • Merck & Co., Inc.
  • Oncolytics Biotech, Inc.
  • Viralytics Ltd.
  • Shanghai Sunway Biotech Co., Ltd.
  • SillaJen, Inc.
  • RIGVIR Ltd.
  • ORYX GmbH & Co. KG
  • Cold Genesys, Inc.
  • Transgene Biotek Ltd.

GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Vaccinia Virus-based Oncolytic Viruses
  • Vesicular Stomatitis Virus-based Oncolytic Viruses
  • HSV-based Oncolytic Viruses
  • Adenovirus-based Oncolytic Viruses
  • Newcastle Disease Virus-based Oncolytic Viruses

GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Prostate Cancer
  • Bladder Cancer
  • Melanoma
  • Ovarian Cancer
  • Breast Cancer
  • Lung Cancer
  • Myeloma
  • Others

GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Specialty Clinics
  • Hospitals
  • Cancer Research Institutes

GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Oncolytic Virus Immunotherapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Oncolytic Virus Immunotherapy Market Snippet by Product Type
    • 2.1.2. Oncolytic Virus Immunotherapy Market Snippet by Application
    • 2.1.3. Oncolytic Virus Immunotherapy Market Snippet by End-User
    • 2.1.4. Oncolytic Virus Immunotherapy Market Snippet by Country
    • 2.1.5. Oncolytic Virus Immunotherapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Oncolytic Virus Immunotherapy Key Market Trends

  • 3.1. Oncolytic Virus Immunotherapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Oncolytic Virus Immunotherapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Oncolytic Virus Immunotherapy Market Opportunities
  • 3.4. Oncolytic Virus Immunotherapy Market Future Trends

4. Oncolytic Virus Immunotherapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Oncolytic Virus Immunotherapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Oncolytic Virus Immunotherapy Market Landscape

  • 6.1. Oncolytic Virus Immunotherapy Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Oncolytic Virus Immunotherapy Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Vaccinia Virus-based Oncolytic Viruses
    • 7.1.3. Vesicular Stomatitis Virus-based Oncolytic Viruses
    • 7.1.4. HSV-based Oncolytic Viruses
    • 7.1.5. Adenovirus-based Oncolytic Viruses
    • 7.1.6. Newcastle Disease Virus-based Oncolytic Viruses

8. Oncolytic Virus Immunotherapy Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Prostate Cancer
    • 8.1.3. Bladder Cancer
    • 8.1.4. Melanoma
    • 8.1.5. Ovarian Cancer
    • 8.1.6. Breast Cancer
    • 8.1.7. Lung Cancer
    • 8.1.8. Myeloma
    • 8.1.9. Others

9. Oncolytic Virus Immunotherapy Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Specialty Clinics
    • 9.1.3. Hospitals
    • 9.1.4. Cancer Research Institutes

10. Oncolytic Virus Immunotherapy Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Oncolytic Virus Immunotherapy Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Oncolytic Virus Immunotherapy Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Oncolytic Virus Immunotherapy Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Oncolytic Virus Immunotherapy Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Oncolytic Virus Immunotherapy Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Oncolytic Virus Immunotherapy Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Amgen, Inc.
    • 11.2.2. Sorrento Therapeutics Inc.
    • 11.2.3. Merck & Co., Inc.
    • 11.2.4. Oncolytics Biotech, Inc.
    • 11.2.5. Viralytics Ltd.
    • 11.2.6. Shanghai Sunway Biotech Co., Ltd.
    • 11.2.7. SillaJen, Inc.
    • 11.2.8. RIGVIR Ltd.
    • 11.2.9. ORYX GmbH & Co. KG
    • 11.2.10. Cold Genesys, Inc.
    • 11.2.11. Transgene Biotek Ltd.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us